DK1315491T3 - Anvendelse af substituerede pyrazoler til fremstilling af et medikament til behandling af allergier - Google Patents
Anvendelse af substituerede pyrazoler til fremstilling af et medikament til behandling af allergierInfo
- Publication number
- DK1315491T3 DK1315491T3 DK01968486T DK01968486T DK1315491T3 DK 1315491 T3 DK1315491 T3 DK 1315491T3 DK 01968486 T DK01968486 T DK 01968486T DK 01968486 T DK01968486 T DK 01968486T DK 1315491 T3 DK1315491 T3 DK 1315491T3
- Authority
- DK
- Denmark
- Prior art keywords
- allergies
- drug
- manufacture
- treatment
- substituted pyrazoles
- Prior art date
Links
- 150000003217 pyrazoles Chemical class 0.000 title abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 206010027654 Allergic conditions Diseases 0.000 abstract 2
- 206010003645 Atopy Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23040700P | 2000-09-06 | 2000-09-06 | |
| US09/928,122 US7309703B2 (en) | 2000-08-14 | 2001-08-10 | Substituted pyrazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1315491T3 true DK1315491T3 (da) | 2006-10-30 |
Family
ID=26924204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01968486T DK1315491T3 (da) | 2000-09-06 | 2001-09-05 | Anvendelse af substituerede pyrazoler til fremstilling af et medikament til behandling af allergier |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1315491B1 (fr) |
| JP (1) | JP2004508329A (fr) |
| CN (1) | CN100384420C (fr) |
| AT (1) | ATE335472T1 (fr) |
| AU (2) | AU8873001A (fr) |
| CA (1) | CA2421505A1 (fr) |
| CY (1) | CY1106196T1 (fr) |
| DE (1) | DE60122171T2 (fr) |
| DK (1) | DK1315491T3 (fr) |
| ES (1) | ES2269454T3 (fr) |
| HK (1) | HK1053606A1 (fr) |
| MX (1) | MXPA03001964A (fr) |
| NZ (1) | NZ524680A (fr) |
| PT (1) | PT1315491E (fr) |
| WO (1) | WO2002020012A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7589202B2 (en) * | 2000-08-14 | 2009-09-15 | Ortho Mcneil Pharmaceutical, Inc. | Substituted pyrazoles |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5944312B2 (ja) * | 1974-11-22 | 1984-10-29 | 中外製薬株式会社 | インダゾ−ル誘導体の製法 |
| JPS5936627B2 (ja) * | 1975-07-25 | 1984-09-05 | 中外製薬株式会社 | インダゾ−ル誘導体の製法 |
| DK27383A (da) * | 1982-02-17 | 1983-08-18 | Lepetit Spa | Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner |
| JPH0615542B2 (ja) * | 1986-07-22 | 1994-03-02 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
| AU7553198A (en) * | 1997-06-12 | 1998-12-30 | Sumitomo Pharmaceuticals Company, Limited | Pyrazole derivatives |
-
2001
- 2001-09-05 CN CNB018182720A patent/CN100384420C/zh not_active Expired - Fee Related
- 2001-09-05 DE DE60122171T patent/DE60122171T2/de not_active Expired - Fee Related
- 2001-09-05 ES ES01968486T patent/ES2269454T3/es not_active Expired - Lifetime
- 2001-09-05 NZ NZ524680A patent/NZ524680A/en unknown
- 2001-09-05 JP JP2002524496A patent/JP2004508329A/ja active Pending
- 2001-09-05 MX MXPA03001964A patent/MXPA03001964A/es active IP Right Grant
- 2001-09-05 AU AU8873001A patent/AU8873001A/xx active Pending
- 2001-09-05 EP EP01968486A patent/EP1315491B1/fr not_active Expired - Lifetime
- 2001-09-05 DK DK01968486T patent/DK1315491T3/da active
- 2001-09-05 WO PCT/US2001/027479 patent/WO2002020012A2/fr active Application Filing
- 2001-09-05 CA CA002421505A patent/CA2421505A1/fr not_active Abandoned
- 2001-09-05 PT PT01968486T patent/PT1315491E/pt unknown
- 2001-09-05 AT AT01968486T patent/ATE335472T1/de not_active IP Right Cessation
- 2001-09-05 AU AU2001288730A patent/AU2001288730B2/en not_active Ceased
-
2003
- 2003-08-15 HK HK03105865A patent/HK1053606A1/xx not_active IP Right Cessation
-
2006
- 2006-10-12 CY CY20061101469T patent/CY1106196T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU8873001A (en) | 2002-03-22 |
| NZ524680A (en) | 2004-09-24 |
| CN1482911A (zh) | 2004-03-17 |
| WO2002020012A3 (fr) | 2002-06-13 |
| WO2002020012A2 (fr) | 2002-03-14 |
| ES2269454T3 (es) | 2007-04-01 |
| HK1053606A1 (en) | 2003-10-31 |
| MXPA03001964A (es) | 2004-03-26 |
| EP1315491A2 (fr) | 2003-06-04 |
| CN100384420C (zh) | 2008-04-30 |
| EP1315491B1 (fr) | 2006-08-09 |
| DE60122171T2 (de) | 2007-07-05 |
| ATE335472T1 (de) | 2006-09-15 |
| DE60122171D1 (de) | 2006-09-21 |
| JP2004508329A (ja) | 2004-03-18 |
| AU2001288730B2 (en) | 2006-01-19 |
| PT1315491E (pt) | 2006-10-31 |
| CA2421505A1 (fr) | 2002-03-14 |
| CY1106196T1 (el) | 2011-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60136546D1 (de) | Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen | |
| DE60219793D1 (de) | Methode zur behandlung von zytokinvermittelten erkrankungen | |
| EA200600203A1 (ru) | Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2 | |
| NO20055516L (no) | Kannabinoidreceptorligander og anvendelser derav | |
| ATE556059T1 (de) | Pyrazolderivate zur behandlung von hiv | |
| CY1108446T1 (el) | Μη νευροτοξικοι παραγοντες ενεργοποιησης πλασμινογονου για την αντιμετωπιση αποπληξιας | |
| DK1315492T3 (da) | Anvendelse af substituerede pyrazoler til behandling af allergier | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
| ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| DE60328603D1 (de) | Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren | |
| DK1438034T3 (da) | Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens | |
| DK1315491T3 (da) | Anvendelse af substituerede pyrazoler til fremstilling af et medikament til behandling af allergier | |
| NO20053562L (no) | Nye aminobenzofenonforbindelser | |
| DK1368023T3 (da) | Anvendelse af buprenoprphin til behandling af urininkontinens | |
| DK1521752T3 (da) | Makrocykliske forbindelser til behandling af cancer | |
| DK1366033T3 (da) | Kemiske forbindelser | |
| ATE344666T1 (de) | Pyridin-2-yl-methylamin-derivate zur behandlung von opiatsucht |